Certificate

Brand

Panagene

Product Type

Reagents

Highlights

The PANA RealTyper™ HPV Screening Kit is an in vitro diagnostic reagent for detecting of human papilloma virus (HPV) from common specimen type, cervical swab and liquid based cytology (LBC) sample.

The PANA RealTyper™ HPV Screening Kit is a CE marked diagnostic device in accordance with the European Union in vitro Diagnostic Medical Device Directive 98/79/EC

Application

The PANA RealTyper™ HPV Screening Kit is an in vitro diagnostic reagent for detecting of human papilloma virus (HPV) from common specimen type, cervical swab and liquid based cytology (LBC) sample. This kit is an amplified DNA test for the qualitative detection of a total of 14 high-risk (HR) HPV types and 2 low-risk (LR) HPV types in a real-time PCR (polymerase chain reaction) system. This kit specially identifies 2 HR types such as 16 and 18 and 2 LR types such as 6 and 11 while concurrently detecting the other HR HPV types that includes 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66 and 68.

Other information

▶ Supplier

Panagene

▶ Order Information:

PANARealTyperTM HPV Screening Kit

Code: PNAM-5001

Package: 96 Tests/Kit

Related Products

Quick-16S Plus NGS Library Prep Kit (V3-V4, UDI)

The Quick-16S Plus NGS Library Prep Kit (V3-V4, UDI) is the fastest and simplest NGS library prep targeting the V3-V4 region of the 16S rRNA gene for high-throughput sequencing. The automation-friendly protocol utilizes a single qPCR/PCR for combined targeted amplification and barcode addition using specially designed primers. After pooling by equal volume, a single clean-up of the final library is performed, rather than massive AMPure® bead-based clean-ups. Additional library quantification analysis such as TapeStation® analysis or gel electrophoresis are not necessary. With these features, the workflow dramatically reduces the hands-on time of library preparation to only 30 minutes.

EntroGen NGS Targeted Hotspot Panel

The EntroGen NGS Targeted Hotspot Panel is a comprehensive assay that detects clinically relevant mutations in solid tumors using next-generation sequencing, compatible with fresh frozen and FFPE samples. It offers high sensitivity, low DNA input, and the ability to batch up to 12 samples in a single run, making it ideal for labs with limited sample volumes.

GeneProof Adenovirus PCR Kit

DETECTION OF ALL HUMAN ADENOVIRUS SPECIES

The kit enables detection of Adenovirus respiratory species A–D, G and gastrointestinal species E-F

WIDE RANGE OF VALIDATED CLINICAL MATERIALS

  • Validated specimen: aspirate, plasma, stool, swab, urine, whole blood
  • Enables detection of both respiratory and gastrointestinal samples

Illumina COVIDSeq ™ Assay (96 samples)

Certificate: ROU 

Supplier: Illumina 

For Mid and Low-throughput laboratories performing COVID-19 surveillance and identification of new variants

BRCAaccuTest™ & BRCAaccuTest™PLUS

BRCAaccuTest™ PLUS with CE-IVD certificate for HBOC Breast/Ovarian Cancer Test

PANA RealTyper™ STD Kit

The PANA RealTyper™ STD Kit is an in vitro diagnostic reagent for genotyping of 13 pathogens involved in sexually transmitted infections (STI) from vaginal swab and urine.

The PANA RealTyper™ STD Kit is a CE marked diagnostic device in accordance with the European Union in vitro Diagnostic Medical Device Directive 98/79/EC.

Next-Generation Sequencing System – NovaSeq 6000

Model: NovaSeq 6000
Manufacturer: Illumina/USA
– Scalable platform
Match data output, time to results, and price per sample to study needs
– Flexible performance
Configure sequencing method, flow cell type, and read length to support a broad range of applications
– Streamlined operation
Increase lab efficiency with a simplified workflow and reduced hands-on time

Next Generation Sequencing System – iSeq 100

Model: iSeq 100
Manufacturer: Illumina/USA
Illumina’s smallest next-generation DNA sequencing system, with small, fast and efficient sequencing throughput, suitable for all labs
– Fast data generation: Suitable for small projects, on a dedicated device, low throughput with fast turnaround times
– Convenient operation: Control the sequencing process from start to finish and ensure independent sequencing instead of outsourcing.

TruSight® Tumor 26

TruSight Tumor 26 Kit includes library preparation reagent set and uses next-generation sequencing (NGS) technology to provide a comprehensive assessment of 26 genes that are commonly related to mutations in solid tumors and somatic variants

TruSight Cancer Sequencing Panel

Developed with cancer genomics experts in collaboration, oligos ready-to-use, pre-engineered oligos allow researchers to sequence a wide range of genes and single nucleotide polymorphisms (SNPs) in advance. this is related to cancer predisposition